Stockreport

Ocugen to Present at Industry and Investor Conferences in October 2025 [Yahoo! Finance]

Ocugen, Inc.  (OCGN) 
PDF biotechnology leader in gene therapies for blindness diseases, today announced that executive leadership will present at the 2025 Cell & Gene Meeting on the Mesa, Charda [Read more]